ArticleJournal of translational medicine2026
Discovery of XNW5004 as a novel EZH2 inhibitor that enhances anti-tumor immunity and synergizes with PD-1 blockade immunotherapy in lung adenocarcinoma.
Zhihuan Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.